Álvaro Sosa Liprandi1, Ezequiel José Zaidel1, Ricardo Lopez Santi2, John Jairo Araujo3, Manuel Alfonso Baños González4, Juan Martín Busso5, Luz Cabral6, Jorge Camilletti2, Juan Erriest2, Roberto Flores7, Ezequiel Forte8, Mirecly Guzman Ramos9, Máxima Mendez Castillo10, Leonardo Josué Ramírez Zambrano11, Carmen Roa12, Piero Custodio-Sanchez13, Gustavo Solache Ortiz14, Bernardo Spitz15, Adrián Baranchuk16. 1. Sanatorio Güemes, Buenos Aires C1180AAX, Argentina. 2. Hospital Italiano de La Plata, La Plata B1900, Argentina. 3. Centro Cardiovascular Somer Incare, Rionegro 054040, Colombia. 4. Cardiology Department, Universidad Juarez Autónoma de Tabasco, Villahermosa Tabasco 86040, Mexico. 5. Sanatorio San José, Buenos Aires c1425, Argentina. 6. Centro Médico Nacional-Hospital Nacional Itauguá, Itauguá 2740, Paraguay. 7. Hospital Ramón Carrillo, Santiago del Estero G4200, Argentina. 8. CENDIC Centro Diagnóstico Cardiovascular, Concordia E3202, Argentina. 9. IVSS Dr Luis Guada Lacau, Valencia 2300, Venezuela. 10. CEDIMAT, Santo Domingo 10514, Dominican Republic. 11. Centro Clínico San Cristobal, San Cristobal 5001, Venezuela. 12. Hospital Metropolitano de Santiago, Santo Domingo 51000, Dominican Republic. 13. Hospital Nacional Almanzor Aguinaga Asenjo -Essalud, Chiclayo 14001, Peru. 14. Instituto de Cardiología Preventiva, San Juan del Río 76800, Mexico. 15. Clínica Cuyo, Mendoza M5500, Argentina. 16. Queen's University, Kingston, ON K7L 3N6, Canada.
Abstract
BACKGROUND: Influenza vaccination (IV) and Pneumococcus vaccination (PV) are recommended for patients with cardiometabolic diseases. This study aimed to evaluate the immunization rate of ambulatory cardiometabolic patients during the COVID-19 pandemic in the Americas. METHODS: Electronic surveys were collected from 13 Spanish speaking countries between 15 June and 15 July 2020. RESULTS: 4216 patients were analyzed. Mean age 60 (±15) years and 49% females. Global IV rate was 46.5% and PV 24.6%. Vaccinated patients were older (IV = 63 vs. 58 years; PV = 68 vs. 59, p < 0.01) but without gender difference. Vaccination rates were greater in higher-risk groups (65+, diabetics, heart failure), but not in coronary artery disease patients. In the Southern cone, the rate of IV and PV was approximately double that in the tropical regions of the Americas. In a multivariate model, geographic zone (IV = OR 2.02, PV = OR 2.42, p < 0.001), age (IV = OR 1.023, PV = OR 1.035, p < 0.001), and incomes (IV = OR 1.28, PV = OR 1.58, p < 0.001) were predictors for vaccination. CONCLUSIONS: During the COVID-19 pandemic, ambulatory patients with cardiometabolic diseases from the Americas with no evidence of COVID-19 infection had lower-than-expected rates of IV and PV. Geographic, social, and cultural differences were found, and they should be explored in depth.
BACKGROUND: Influenza vaccination (IV) and Pneumococcus vaccination (PV) are recommended for patients with cardiometabolic diseases. This study aimed to evaluate the immunization rate of ambulatory cardiometabolic patients during the COVID-19 pandemic in the Americas. METHODS: Electronic surveys were collected from 13 Spanish speaking countries between 15 June and 15 July 2020. RESULTS: 4216 patients were analyzed. Mean age 60 (±15) years and 49% females. Global IV rate was 46.5% and PV 24.6%. Vaccinated patients were older (IV = 63 vs. 58 years; PV = 68 vs. 59, p < 0.01) but without gender difference. Vaccination rates were greater in higher-risk groups (65+, diabetics, heart failure), but not in coronary artery disease patients. In the Southern cone, the rate of IV and PV was approximately double that in the tropical regions of the Americas. In a multivariate model, geographic zone (IV = OR 2.02, PV = OR 2.42, p < 0.001), age (IV = OR 1.023, PV = OR 1.035, p < 0.001), and incomes (IV = OR 1.28, PV = OR 1.58, p < 0.001) were predictors for vaccination. CONCLUSIONS: During the COVID-19 pandemic, ambulatory patients with cardiometabolic diseases from the Americas with no evidence of COVID-19 infection had lower-than-expected rates of IV and PV. Geographic, social, and cultural differences were found, and they should be explored in depth.
Authors: Erik von Elm; Douglas G Altman; Matthias Egger; Stuart J Pocock; Peter C Gøtzsche; Jan P Vandenbroucke Journal: Lancet Date: 2007-10-20 Impact factor: 79.321
Authors: Kristin L Nichol; James Nordin; John Mullooly; Richard Lask; Kelly Fillbrandt; Marika Iwane Journal: N Engl J Med Date: 2003-04-03 Impact factor: 91.245
Authors: Jeffrey C Kwong; Kevin L Schwartz; Michael A Campitelli; Hannah Chung; Natasha S Crowcroft; Timothy Karnauchow; Kevin Katz; Dennis T Ko; Allison J McGeer; Dayre McNally; David C Richardson; Laura C Rosella; Andrew Simor; Marek Smieja; George Zahariadis; Jonathan B Gubbay Journal: N Engl J Med Date: 2018-01-25 Impact factor: 91.245
Authors: Jacob A Udell; Rami Zawi; Deepak L Bhatt; Maryam Keshtkar-Jahromi; Fiona Gaughran; Arintaya Phrommintikul; Andrzej Ciszewski; Hossein Vakili; Elaine B Hoffman; Michael E Farkouh; Christopher P Cannon Journal: JAMA Date: 2013-10-23 Impact factor: 56.272
Authors: Ricardo Lopez Santi; Daniel Leonardo Piskorz; Manlio F Marquez; Cristhian Ramirez Ramos; Nicolás Federico Renna; Martin Ibarrola; Fernando Stuardo Wyss; Adrián Naranjo Dominguez; Gonzalo Emanuel Perez; Juan María Farina; Ezequiel Forte; Jorge Paul Juarez Lloclla; Emma Flores de Espinal; Adriana Puente Barragan; Mauro Gabriel Ruise; Diego Delgado; Adrian Baranchuk Journal: CJC Open Date: 2020-08-28